Abstract Purpose of Review Recent studies have demonstrated an important role for
inflammation in the pathogenesis of atherosclerotic cardiovascular disease. Several studies …

Abstract Purpose of Review Inflammation is involved in the initiation, progression, and
destabilization of atherosclerosis. Anti-inflammatory strategies aimed at reducing residual …

Aims Inflammation plays a central role in the pathogenesis and clinical manifestations of
atherosclerosis. Randomized controlled trials have investigated the potential benefit of …

Inflammation plays a central role in coronary artery disease (CAD), and recent data have
shown that anti-inflammatory drugs have the potential to reduce ischemic events in CAD …

Background Inflammation plays a pivotal role in coronary artery disease (CAD). The anti‐
inflammatory drug colchicine seems to reduce ischemic events in patients with CAD. So far …

Background Inflammatory plays a key role in the development of coronary artery disease
(CAD). Colchicine as an anti-inflammatory treatment for CAD has attracted much attention …

Purpose Colchicine is a widely available, inexpensive drug with a range of antiinflammatory
properties that may make it suitable for the secondary prevention of atherosclerosis. This …

Inflammation as a cardiovascular risk factor has attracted increasing attention. The current
standard of care for decreasing the occurrence of cardiovascular events includes controlling …

Abstract Purpose of Review This review focuses on the use of colchicine to target
inflammation to prevent cardiovascular events among those at-risk for or with established …

Abstract Purpose of Review Targeting traditional cardiovascular risk factors is effective in
reducing recurrent cardiovascular events, yet the presence of residual cardiovascular risk …